Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Head and Neck Cancers

11 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    VICCHN0356

    02/04/2003

    Head and Neck Tumor Tissue Repository and Clinical Database

    Health Services Research

    VICCHN1533

    09/28/2016

    Characterization of Cardiac Function, Pulmonary Function, and Body Composition Before and After Concurrent Chemoradiotherapy for Head and Neck Cancer

    Other

    VICCHN15135

    09/28/2016

    Assessing Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors

    Other

    VICCSUPP14137

    08/30/2016

    Characterization of Chronic Systemic Symptoms among Participants in the Fibrosis Lymphedema Continuum Study in Head and Neck Cancer

    Supportive Care

    VICCSUPP1529

    06/08/2015

    Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

    Treatment

    VICCMD1636

    12/21/2016

    A Phase 1b/2 Open-Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies

    Treatment

    VICCMD15110

    04/05/2016

    A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

    Treatment

    VICCHN1574

    03/21/2016

    A Randomized, Multicenter, Double-Blind Phase 2 Study of Palbociclib plus Cetuximab versus Cetuximab for the Treatment of Human Papillomavirus -Negative, Cetuximab-Naive Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck After Failure of One Prior Platinum-Containing Chemotherapy Regimen

    Treatment

    VICCPHI1531

    03/01/2016

    A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers

    Treatment

    VICCPHI1588

    11/27/2015

    A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors

    Treatment

    ECOGHNE1305-M

    02/11/2009

    A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer


    Print this page for your doctor